Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients
Open Access
- 27 July 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 30 (1), 70-7
- https://doi.org/10.1186/1756-9966-30-70
Abstract
Background To examine the expression of SMAD4 at gene and protein levels in glioma samples with different WHO grades and its association with survival. Methods Two hundreds fifty-two glioma specimens and 42 normal control tissues were collected. Immunochemistry assay, quantitative real-time PCR and Western blot analysis were carried out to investigate the expression of SMAD4. Kaplan-Meier method and Cox's proportional hazards model were used in survival analysis. Results Immunohistochemistry showed that SMAD4 expression was decreased in glioma. SMAD4 mRNA and protein levels were both lower in glioma compared to control on real-time PCR and Western blot analysis (both P < 0.001). In addition, its expression levels decrease from grade I to grade IV glioma according to the results of real-time PCR, immunohistochemistry analysis and Western blot. Moreover, the survival rate of SMAD4-positive patients was higher than that of SMAD4-negative patients. We further confirmed that the loss of SMAD4 was a significant and independent prognostic indicator in glioma by multivariate analysis. Conclusions Our data provides convincing evidence for the first time that the reduced expression of SMAD4 at gene and protein levels is correlated with poor outcome in patients with glioma. SMAD4 may play an inhibitive role during the development of glioma and may be a potential prognosis predictor of glioma.Keywords
This publication has 21 references indexed in Scilit:
- Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant gliomaTumor Biology, 2010
- Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammationJCI Insight, 2009
- Smad4: gatekeeper gene in head and neck squamous cell carcinomaJCI Insight, 2009
- Promoter‐wide analysis of Smad4 binding sites in human epithelial cellsCancer Science, 2009
- Strong Smad4 Expression Correlates with Poor Prognosis After Surgery in Patients with Hepatocellular CarcinomaAnnals of Surgical Oncology, 2009
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic CancerClinical Cancer Research, 2009
- Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patientsJournal of Neuro-Oncology, 2009
- Immunohistochemical expression of P15 (INK4B) and SMAD4 in advanced gastric cancer.2008
- Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomasHuman Pathology, 2005
- Published by Stichting OpenAccess Foundation